Research: ACRE advice: application for a trial of genetically modified Bordetella Pertussis (21/R53/01) and (22/R53/01)

⌂Back To Homepage Subscribe To RSS Feed

Advisory Committee On Releases To The Environment

June 23

13:17 2022

Print This Article Share it With Friends

Created by Advisory Committee On Releases To The Environment 0 comments

Advice on an application for deliberate release of a GMO for research and development purposes

PDF, 77.5 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email defra.helpline@defra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

These documents are the advice of the Advisory Committee on Releases to the Environment (ACRE) to government on 2 applications from ILiAD Biotechnologies LLC to carry out trials, in subsequent years, of genetically modified Bordetella Pertussis.

The committee advised that the risks to human health and the environment from this trial are extremely low.

Published 23 June 2022

Your name:	Your email:
Comments:
Post my comment

GovWire